GGrantIndex
Sort

15,440 grants matching organoids

Functional long noncoding RNAs in neural development

$630,472
Daniel A Lim · University Of California, San Francisco · R01 · FY2022 · NS

AN INTEGRATED PLATFORM FOR NOVEL PERSONALIZED LIVER CANCER THERAPEUTICS

$630,404
Ernesto Guccione · Icahn School Of Medicine At Mount Sinai · R01 · FY2025 · CA

Optical imaging of pancreas cancer organoids for drug development and personalized treatment

$630,364
Melissa Caroline Skala · Morgridge Institute For Research, Inc. · R01 · FY2018 · CA

Core A: Biospecimen and Pathology

$630,250
Deborah Dillon · Dana-Farber Cancer Inst · P50 · FY2025 · CA

IDENTIFICATION AND PRECLINICAL EVALUATION OF NOVEL THERAPEUTIC APPROACHES TO DYSKERATOSIS CONGENITA

$630,241
Frederick Bradley Johnson · University Of Pennsylvania · R01 · FY2021 · HL

Therapeutic Optimization of Productive Repair After Acute Kidney Injury

$630,202
Neil A Hukriede · University Of Pittsburgh At Pittsburgh · UC2 · FY2020 · DK

Therapeutic Optimization of Productive Repair After Acute Kidney Injury

$630,202
Neil A Hukriede · University Of Pittsburgh At Pittsburgh · UC2 · FY2021 · DK

Therapeutic Optimization of Productive Repair After Acute Kidney Injury

$630,202
Neil A Hukriede · University Of Pittsburgh At Pittsburgh · UC2 · FY2022 · DK

Organization and Dynamics of Endomembrane Pathways and Organelles

$630,146
Jennifer Lippincott-Schwartz · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2018 · HD

Mechanics of Vertebrate Embryo Elongation

$630,141
Olivier Pourquie · Brigham And Women'S Hospital · R01 · FY2025 · HD

Mechanics of Vertebrate Embryo Elongation

$630,141
Olivier Pourquie · Brigham And Women'S Hospital · R01 · FY2024 · HD

Synthetic gene sensors and effectors to redirect organoid development

$629,970
Ron Weiss · Massachusetts Institute Of Technology · R01 · FY2024 · EB

Multiplexed drug testing of micro-dissected tumors using a microfluidic platform with integrated electrochemical aptasensors

$629,966
Albert Folch · University Of Washington · R01 · FY2024 · CA

Quantitative Computational Methods to Accurately Measure Tumor Heterogeneity in Solid Tumors to Inform Development of Evolution-based Treatment Strategies

$629,889
Jeffrey Hsu-Min Chuang · Jackson Laboratory · R01 · FY2019 · CA

IDENTIFICATION AND PRECLINICAL EVALUATION OF NOVEL THERAPEUTIC APPROACHES TO DYSKERATOSIS CONGENITA

$629,822
Frederick Bradley Johnson · University Of Pennsylvania · R01 · FY2022 · HL

Functional optical imaging for rapid, label-free predictions of treatment response and clonal evolution in patient-derived cancer organoids

$629,799
Melissa Caroline Skala · Morgridge Institute For Research, Inc. · R01 · FY2024 · CA

Novel lipid and glutamine metabolism-based combination therapies for glioblastoma

$629,750
Deliang Guo · Ohio State University · R01 · FY2025 · NS

Epithelial Progenitor Cells in Lung Repair and Regeneration

$629,745
Harold A Chapman · University Of California, San Francisco · U01 · FY2013 · HL

Engineering Dual-Targeted Nanoplatforms to Effectively Treat NSCLC.

$629,729
Raghuraman Kannan · University Of Missouri-Columbia · R01 · FY2025 · EB

Multifunctional Regulation of Prostate Cancer Metabolism by Sigma1 Modulators

$629,666
Felix Jinhyun Kim · Thomas Jefferson University · R01 · FY2021 · CA

Hepatoprotective Mechanisms of Systemic Bile Acid Transporter Inhibitors

$629,658
Paul A Dawson · Emory University · R01 · FY2025 · DK

The Role of Adenine Nucleotide Translocase in Mitochondrial Dysfunction Associated Senescence in Chronic Obstructive Pulmonary Disease (COPD)

$629,588
Corrine R Kliment · University Of Pittsburgh At Pittsburgh · R01 · FY2025 · HL

miR-615, AKT/eNOS signaling, and angiogenesis

$629,463
Mark W Feinberg · Brigham And Women'S Hospital · R01 · FY2023 · HL

Tuning translation efficiency to overcome refractory defects in CFTR

$629,319
Kathryn E Oliver · Emory University · R01 · FY2025 · HL

Irreversible Electroporation (IRE) Combined with CD40 Agonism as In Situ Vaccine Therapy for Pancreatic Cancer

$629,181
Rebekah White · University Of California, San Diego · R01 · FY2023 · CA